68 related articles for article (PubMed ID: 8144124)
1. [The nephroprotective effect of ramipril. Effect on blood pressure and metabolic control in insulin-treated patients with type-2 diabetes mellitus].
Jungmann E; Krüger K; Semler B; Haak T; Scherberich J; Schumm-Draeger PM; Usadel KH
Fortschr Med; 1994 Jan; 112(3):39-42. PubMed ID: 8144124
[TBL] [Abstract][Full Text] [Related]
2. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of ramipril in diabetics with mild to moderate hypertension.
Schwartz SL; Hanson C; Lucas C; Rosenblatt S; Rosenstock J; Whittier F; Wistran D; Riche C; Mulcahy WS
Clin Ther; 1993; 15(1):79-87. PubMed ID: 8458057
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
[TBL] [Abstract][Full Text] [Related]
5. [The effect of ramipril on metabolic, renal and cardiac function in hypertension and type II diabetes mellitus].
Vítovec J; Spinar J
Vnitr Lek; 1998 Jun; 44(6):336-41. PubMed ID: 9820056
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
Katavetin P; Eiam-Ong S; Suwanwalaikorn S
J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
8. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
9. [Long-term antihypertensive therapy of diabetic patients with felodipine. Effects of treatment on blood pressure and kidney function parameters].
Jungmann E; Schumm-Draeger PM; Scheuermann EH; Usadel KH
Fortschr Med; 1992 Apr; 110(12):224-6. PubMed ID: 1601370
[TBL] [Abstract][Full Text] [Related]
10. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.
Dominguez JR; de la Calle H; Hurtado A; Robles RG; Sancho-Rof J
Postgrad Med J; 1986; 62 Suppl 1():66-8. PubMed ID: 3534865
[TBL] [Abstract][Full Text] [Related]
11. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
Schwarz C; Oberbauer R
Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
[TBL] [Abstract][Full Text] [Related]
12. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
Estacio RO; Jeffers BW; Gifford N; Schrier RW
Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
16. Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus.
Borcea V; Morcos M; Isermann B; Henkels M; Ziegler S; Zumbach M; Amiral J; Längst KD; Seiz W; Ziegler R; Wahl P; Nawroth PP
Vasa; 1999 Aug; 28(3):172-80. PubMed ID: 10483322
[TBL] [Abstract][Full Text] [Related]
17. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
Ravid M; Lang R; Rachmani R; Lishner M
Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
[TBL] [Abstract][Full Text] [Related]
18. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*.
Schrader J; Lüders S; Kulschewski A; Hammersen F; Züchner C; Venneklaas U; Schrandt G; Schnieders M; Rangoonwala B; Berger J; Dominiak P; Zidek W;
J Hypertens; 2006 Mar; 24(3):541-8. PubMed ID: 16467658
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
